Comparison of two modes of vitamin B12supplementation on neuroconduction and cognitive function among older people living in Santiago, Chile: a cluster randomized controlled trial. a study protocol [ISRCTN 02694183]

Nutrition Journal

Research

Lindsay Allen¹  José Luis Castillo²  Renato Verdugo²  Manuel Lavados²  Hugo Sánchez³  Lydia Lera³  Cecilia Albala³  Eva Hertrampf³  Alex Brito³  Ricardo Uauy⁴ 

[1] Department of Agriculture, Agricultural Research Services, Western Human Nutrition Research Center, University of California, CP 95616, Davis, CA, USA;Department of Neurology, Faculty of Medicine, University of Chile, Av. José Miguel Infante N° 553, CP7500691, Santiago, Chile;Public Health Nutrition Unit, Institute of Nutrition and Food Technology (INTA), University of Chile, El Libano 5524, CP783490, Santiago, Chile;Public Health Nutrition Unit, Institute of Nutrition and Food Technology (INTA), University of Chile, El Libano 5524, CP783490, Santiago, Chile;Department of Nutrition and Public Health Intervention Research, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, WC1E 7HT, London, UK;

关键词: cobalamin;    vitamin B12;    cyanocobalamin;    elderly;    neurophysiology;    cognitive disorders;    nerve conduction;    cluster randomized controlled trial;    public health;    Chile;   

DOI  :  10.1186/1475-2891-10-100

 received in 2011-03-31, accepted in 2011-09-27,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundOlder people have a high risk of vitamin B12 deficiency; this can lead to varying degrees of cognitive and neurological impairment. CBL deficiency may present as macrocytic anemia, subacute combined degeneration of the spinal cord, or as neuropathy, but is often asymptomatic in older people. Less is known about subclinical vitamin B12 deficiency and concurrent neuroconduction and cognitive impairment. A Programme of Complementary Feeding for the Older Population (PACAM) in Chile delivers 2 complementary fortified foods that provide approximately 1.4 μg/day of vitamin B12 (2.4 μg/day elderly RDA). The aim of the present study is to assess whether supplementation with vitamin B12 will improve neuroconduction and cognitive function in older people who have biochemical evidence of vitamin B12 insufficiency in the absence of clinical deficiency.MethodsWe designed a cluster double-blind placebo-controlled trial involving community dwelling people aged 70-79 living in Santiago, Chile. We randomized 15 clusters (health centers) involving 300 people (20 per cluster). Each cluster will be randomly assigned to one of three arms: a) a 1 mg vitamin B12 pill taken daily and a routine PACAM food; b) a placebo pill and the milk-PACAM food fortified to provide 1 mg of vitamin B12; c) the routine PACAM food and a placebo pill.The study has been designed as an 18 month follow up period. The primary outcomes assessed at baseline, 4, 9 and 18 months will be: serum levels of vitamin B12, neuroconduction and cognitive function.ConclusionsIn view of the high prevalence of vitamin B12 deficiency in later life, the present study has potential public health interest because since it will measure the impact of the existing program of complementary feeding as compared to two options that provide higher vitamin B12 intakes that might potentially may contribute in preserving neurophysiologic and cognitive function and thus improve quality of life for older people in Chile.Trial registrationISRCTN: ISRCTN02694183

【 授权许可】

CC BY   
© Sánchez et al; licensee BioMed Central Ltd. 2011